NASDAQ:PHAT

Phathom Pharmaceuticals Stock Insider Trading

etoro logo Buy PHAT
*Your capital is at risk
$10.09
+0.440 (+4.56%)
At Close: Jun 03, 2026

Phathom Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 83.96. In total, the insiders bought 3.38M and sold 365.36K PHAT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
83.96
Buy 3.38M shares
Sell 365.36K shares
80% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
May 22, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 83.96.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 13, 2026
Buy
Common Stock (Right to Buy)
M-Exempt
Parikh Asit
Director
Director 8 750
Value: $90.1K
Jan 02, 2026
Buy
Common Stock
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 82 715
Value: $1.30M
Jan 02, 2026
Buy
Stock Option (Right to Buy)
A-Award
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
Officer 67 878
Value: $1.07M
Jan 02, 2026
Buy
Common Stock
A-Award
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
Officer 75 345
Value: $1.18M
Jan 02, 2026
Buy
Common Stock
A-Award
Basta Steven L
President And CEO
CEO / President 251 034
Value: $3.94M
Jan 02, 2026
Buy
Stock Option (Right to Buy)
A-Award
Basta Steven L
President And CEO
CEO / President 226 156
Value: $3.55M
Jan 02, 2026
Buy
Stock Option (Right to Buy)
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 42 848
Value: $673.1K
Dec 19, 2025
Buy
Common Stock (Right to Buy)
M-Exempt
Parikh Asit
Director
Director 8 750
Value: $90.1K
Dec 19, 2025
Buy
Common Stock
M-Exempt
Parikh Asit
Director
Director 8 750
Value: $90.1K
Dec 18, 2025
Sell
Common Stock
F-InKind
Breedlove Robert Charles
Principal Accounting Officer
Officer 230
Value: $4K
Dec 17, 2025
Buy
Common Stock
A-Award
Basta Steven L
President And CEO
CEO / President 62 038
Value: $952.9K
Dec 17, 2025
Buy
Common Stock
A-Award
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
Officer 17 370
Value: $266.8K
Dec 17, 2025
Sell
Common Stock
F-InKind
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
Officer 7 703
Value: $118.3K
Dec 17, 2025
Sell
Common Stock
F-InKind
Basta Steven L
President And CEO
CEO / President 31 502
Value: $483.9K
Nov 28, 2025
Buy
Performance Shares
M-Exempt
Basta Steven L
President And CEO
CEO / President 90 000
Value: $1.41M
Nov 28, 2025
Buy
Common Stock
M-Exempt
Basta Steven L
President And CEO
CEO / President 90 000
Value: $1.41M
Nov 28, 2025
Sell
Common Stock
F-InKind
Basta Steven L
President And CEO
CEO / President 48 375
Value: $755.6K
Nov 03, 2025
Sell
Common Stock
S-Sale
Breedlove Robert Charles
Principal Accounting Officer
Officer 524
Value: $7K
Oct 06, 2025
Buy
Common Stock
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 144 000
Value: $1.67M
Oct 06, 2025
Buy
Common Stock
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 144 000
Value: $1.67M
Oct 06, 2025
Buy
Stock Option (Right to Buy)
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 200 000
Value: $2.32M
Oct 06, 2025
Buy
No securities are beneficially owned.
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 0
Value: $0
Oct 06, 2025
Buy
No securities are beneficially owned.
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 0
Value: $0
Oct 06, 2025
Buy
Stock Option (Right to Buy)
A-Award
Narula Sanjeev
Chief Financial & Bus. Officer
Officer 200 000
Value: $2.32M
Sep 25, 2025
Buy
Performance Shares
M-Exempt
Basta Steven L
President And CEO
CEO / President 90 000
Value: $1.05M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PHATHOM PHARMACEUTICALS, INC.
Phathom Pharmaceuticals
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE